Compounded medications are not FDA approved. FDA does not review compounded medications for safety, effectiveness, or quality before they are marketed.
Compounded GLP-1 Guidepricing database · evidence ledger

Authors & reviewers

The people accountable for Compounded GLP-1 Guide content. Medical and clinical reviewers are named licensed providers whose NPI records are verified against the public CMS NPPES registry. Medical review is distinct from editorial-governance auditing; each role is scoped below. No credential is displayed that has not been confirmed.

Named reviewers

How review works

Physician-level medical review — medication mechanism, indication, contraindication, dosing context, and regulatory-status language — is performed by our named medical reviewer. Clinical-workflow and patient-care review — provider reviews, care-model comparisons, intake and follow-up — is performed by our lead clinical reviewer. Editorial-governance auditing — adherence to editorial standards, evidence policy, and disclosure — is a separate function and carries no medical-review authority.

Verification note: NPI numbers are public identifiers in the CMS NPPES registry. We confirm each named clinical reviewer's NPI is active and matches the stated name. The NPPES taxonomy is the authoritative record for each provider's licensure and specialty. Profiles for roles whose underlying credentials are not yet independently verified are set to noindex and assert no medical credential. Publisher: US Peptides Partners LLC (see About).